Bush, et al., Supplemental Figure S5.

Sep 05, 2014

10 likes | 87 Vues

Bush, et al., Supplemental Figure S5. A. B. RNA Levels per Cell. C. D. E.

Share Presentation

Embed Code

Link

quantification
rna levels
histone genes
ko mefs
total rna levels
constitutive ko array data

ruana

Télécharger la présentation

Bush, et al., Supplemental Figure S5.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Bush, et al., Supplemental Figure S5. A B RNA Levels per Cell C D E Supplemental Figure S5. (A) Total RNA levels in WT and KO MEFs, (B) qPCR validation of genes downregulated on microarray (C) Histone genes with upregulated expression in constitutive KO – array data. D) Immunoblots of histone H2b and H4. (E) Western blot and associated quantification of CENP-A protein in KO 49 and 52 vs. Mean WT.

Lim et al, Supplemental Figure S1.

Lim et al, Supplemental Figure S1. . a/b. a. a. b/c. a/b. c/d. c/d. c/d. d. e. Arsenic. Plant height (Cm). f. g. [mg/Kg]. 1.5. 5.0. 7.0. 0. 10. 50. 100. 150. 0. 200. 300. 400. 500. 0. As[ μ M]. Cadmium. a/b. a. b. b. c. c. d. d. d/e. e. f. g.

156 views • 5 slides

Patel et al Supplemental Figure S4

A . Patel et al Supplemental Figure S4. 4.1 ± 1.9. SK-ES-1. 13.0 ± 3.8. SK- N-MC. 0. 4. 12. RASSF1A Fold Induction with 5-AZA treatment. B . 39.5 ± 14.5. SK-ES-1. 185.5 ± 45.6. SK- N-MC. 24.3 ± 5.9. A673. 0. 100. 150. 200. 50. CALCA Fold Induction with 5-AZA treatment.

95 views • 1 slides

Supplemental Figure S5

A B C D. Cox-2 fl/fl. Untreated skin 1xTPA skin Skin Papilloma. Same mouse (DMBA/TPA). Supplemental Figure S5.

69 views • 1 slides

Figure S5. Ravichandran et al. 2013

Figure S5. Ravichandran et al. 2013.

95 views • 1 slides

Supplemental Figure 3. Kiem et al.

1500. 600. 300. 200. 100. 1500. 600. 300. 200. 100. Supplemental Figure 3. Kiem et al. a. Copy Number in Foamy Transduced Lymphocytes. 3. 2. Copy Number. 1. 0. FV-SMPGW. FV-UsI-SMPGW. FV-HsI-SMPGW. FV-SC46-IMPGW. FV-UsI-SC46-IMPGW. FV-UsIIUsIUR5-SMPGW. FV-HsIIHsIHR5-SMPGW.

73 views • 1 slides

Zang, et al. Supplemental Figure 2

Zang, et al. Supplemental Figure 2. Non-diabetic Diabetic Diabetic+S17834.

97 views • 1 slides

Yoon et al. Supplemental Figure S1

Yoon et al. Supplemental Figure S1. A. B. AGS. MKN-45. N87. CFPAC-1. PANC-1. AGS. MKN-45. N87. CFPAC-1. PANC-1. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Spheroid. Spheroid. Spheroid. Spheroid.

109 views • 1 slides

Supplemental Figure Fung et al.

Supplemental Figure Fung et al. A. B. Fluorescence and phase-contrast microscopic images showing ( A ) co-culture of MS5-GFP cells with human primary macrophages (including those encircled red). Note stellate network of MS5 cells (white arrows) spanning across an

136 views • 1 slides

Lim et al, Supplemental Figure S1.

Lim et al, Supplemental Figure S1. OsRING-H2 type : 4 OsRING-HC type : 6 OsRING-v type : 2. OsRING-H2 type : 5 OsRING-HC type : 1 OsRING-v type : 1. OsRING-H2 type : 9 OsRING-HC type : 8 OsRING-v type : 2. OsRING-H2 type : 9 OsRING-HC type : 8 OsRING-v type : 2.

206 views • 14 slides

Yoon et al. Supplemental Figure S3

Yoon et al. Supplemental Figure S3. A. AGS MKN-45 N87. Vismodegib. B. 5-fluoruracil. DMSO. Vismodegib. 5-fluoruracil. Cisplatin. Cisplatin. AGS Spheroid. MKN-45 Spheroid. N87 Spheroid.

123 views • 1 slides

Weaver et al. supplemental Figure 1

Weaver et al. supplemental Figure 1. A BALB/c. Epitope. Immunogen. Peptide. B1. B2. B3. B4. B5. B6. B7. B8. B9. B10. B11. B12. UG37(A). KVTFEPIPIHYCAPA (53). STVQCTHGIRPVVST (62). RIKQIINMWQRVGQA (104). GIVQQQSNLLRAIEAQQHLLKLTVWGIKQLQ (136,137,138,140).

103 views • 3 slides

Tsutsumi et al., Supplemental Figure 1

80. 40. 80. 60. 0. 40. 10 0. 10 1. 10 2. 10 3. 20. Negative control. GA-FITC. GA-FITC + DMAG-N-oxide. 0. 10 0. 10 1. 10 2. 10 3. Negative control. mock. DMAG-N-oxide. Tsutsumi et al., Supplemental Figure 1. a. Cell Number (%). Fluorescence Intensity (log). b.

68 views • 1 slides

Bush, et al., Supplemental Figure S3.

Bush, et al., Supplemental Figure S3. B. A. C. WT 1. WT1 -- Normal Karyotype. DAPI. KO2 Endoreduplication. Mean = 1.4%. p value = 0.001. KO1 -- 39, XX, -4, chtb(1), chtb(11), chtb(12). KO 2. DAPI. Mean = 4.4%. E. D.

89 views • 1 slides

Supplemental Figure 1 Narainsamy et al.

Supplemental Figure 1 Narainsamy et al. A. B. Supplemental Figure 2 Narainsamy et al. A. B. 3276. 1375. 757. 1438. Supplemental Figure 3 Narainsamy et al. B. Positive ion mode. Negative ion mode. <10. 10-25. 25-35. 35-50. >50. <10. 10-25. 25-35. 35-50. >50. CV (%).

147 views • 7 slides

Supplemental Figure 1 Purandare et al.

Supplemental Figure 1 Purandare et al. A. B. JAK2. 0 Percent Control Cut-Off. 33 Percent Control Cut-Off.

68 views • 1 slides

Vernin et al., supplemental Figure 5

PI positive cells (%). Vernin et al., supplemental Figure 5.

93 views • 1 slides

Supplemental Figure 1, Ghielmetti et al

Supplemental Figure 1, Ghielmetti et al.

86 views • 1 slides

Supplemental Figure 3, Ghielmetti et al

medium. TB40/E. TB40/E-UV. Supplemental Figure 3, Ghielmetti et al.

98 views • 1 slides

Supplemental Figure 1 Geffroy et al.

CNL-B19. CNL-BA8. l B35. CNL-BA11. l B29. CNL-J11. l J9. Supplemental Figure 1 Geffroy et al. BAT93. JaloEEP558. Genetic position 1. Genetic position 1. 10Kb. CNL-J8. l J39. CNL-JA78. l J107. CNL-J9. l J15. Genetic position 2. CNL-B16. CNL-B17. l B10. Genetic position 3.

101 views • 1 slides

Kiem et al., Supplemental Figure 1

Kiem et al., Supplemental Figure 1. Relative luciferase expression. control. human CCR5-741. human CCR5-1024. macaque CCR5-741. macaque CCR5-1024.

89 views • 1 slides

Glazov et al., Supplemental Figure 6

Glazov et al., Supplemental Figure 6.

117 views • 1 slides

Kuwano et al., Supplemental Figure S1

A. 5’UTR. CR. 3’UTR. MKP-1. 1. 249. 2015. 1352. CR. 3’UTR. 5’UTR. MKP-1. GAPDH. B. 5’UTR CR 3’UTR 3’UTR. RNA :. H 2 O 2 (h) : 0 1 2 0 1 2 0 1 2 0 1 2. HuR NF90.

145 views • 6 slides

More Related